Koyfin Home > Directory > Health Care > Nymox Pharm Corp > Gross Margin

Nymox Pharm Corp Gross Margin Chart (NYMX)

Nymox Pharm Corp annual/quarterly Gross Margin from 2010 to 2020. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Nymox Pharm Corp Gross Margin for the quarter ending March 03, 2020 was $20m a -225.00% decrease of -45m year over year
  • Nymox Pharm Corp Gross Margin for the last 12 months ending June 06, 2020 was $63m a 58.02% increase of 37m year over year
  • Nymox Pharm Corp Annual Gross Margin for 2019 was $50m a -7.69% decrease of -4m from 2018
  • Nymox Pharm Corp Annual Gross Margin for 2018 was $54m a 37.82% increase of 20m from 2017
  • Nymox Pharm Corp Annual Gross Margin for 2017 was $33m a -16.73% decrease of -6m from 2016
Other Margins & Efficiency Metrics:
  • Nymox Pharm Corp EBITDA Margin for the quarter ending March 03, 2015 was $63m a 263.17% increase of 166m year over year
  • Nymox Pharm Corp Return on Capital % for the quarter ending September 09, 2018 was -187.81 a -1,416.11% increase of 2,659.58 year over year
  • Nymox Pharm Corp Return on Equity % for the quarter ending September 09, 2018 was -298.46 a -11.24% increase of 33.54 year over year
View Chart On Koyfin

Quarterly NYMX Gross Margin Data

03/2020$20m
12/2019$73m
09/2019$59m
06/2019$65m
03/2019$3m
12/2018$-53m
09/2018$38m
06/2018$73m
03/2018$61m
12/2017$57m

Annual NYMX Gross Margin Data

2019$50m
2018$54m
2017$33m
2016$39m
2015$94m
2014$94m
2013$86m
2012$92m
2011$91m
2010$54m